FCPM III SERVICES B.V. Long-Term Concentrated

Location: Naarden, Netherlands

CIK: 0002013410 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 17, 2026

Total Value: $763M (100.0% shares, 0.0% debt)

Holdings (10)

NAMS NEWAMSTERDAM PHARMA COMPANY 42.3%

Value $323M Shares 9,198,900 Est. Cost $9.56 Unrealized +280.5%

DYN DYNE THERAPEUTICS INC 14.0%

Value $107M Shares 5,462,846 Est. Cost $12.58 Unrealized +50.6%

ENGN ENGENE HOLDINGS INC 11.4%

Value $86.98M Shares 9,632,561 Est. Cost $10.14 Unrealized -21.0%

RAPT RAPT THERAPEUTICS INC 8.1%

Value $62.09M Shares 1,833,333 Est. Cost $26.66 Unrealized +16.5%

MPLT MAPLIGHT THERAPEUTICS INC 7.4%

Value $56.67M Shares 3,226,400 Est. Cost $16.75 Unrealized 0.0%

VOR VOR BIOPHARMA INC 6.2%

Value $47.31M Shares 3,617,354 Est. Cost $20.89 Unrealized -10.8%

REPL REPLIMUNE GROUP INC 3.6%

Value $27.3M Shares 2,808,368 Est. Cost $11.28 Unrealized -24.7%

BCYC BICYCLE THERAPEUTICS PLC 3.2%

Value $24.56M Shares 3,468,430 Est. Cost $18.38 Unrealized —

CBIO CRESCENT BIOPHARMA INC. 2.6%

Value $19.9M Shares 1,677,852 Est. Cost $12.74 Unrealized 0.0%

ENGNW ENGENE HOLDINGS INC 1.1%

Value $8.519M Shares 2,878,148 Est. Cost $0.63 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
NAMS	NEWAMSTERDAM PHARMA COMPANY	9,198,900	$323M	42.3%	$9.56	+280.5%	ORDINARY SHARES	N62509109
DYN	DYNE THERAPEUTICS INC	5,462,846	$107M	14.0%	$12.58	+50.6%	COM	26818M108
ENGN	ENGENE HOLDINGS INC	9,632,561	$86.98M	11.4%	$10.14	-21.0%	COM	29286M105
RAPT	RAPT THERAPEUTICS INC	1,833,333	$62.09M	8.1%	$26.66	+16.5%	COM NEW	75382E208
MPLT	MAPLIGHT THERAPEUTICS INC	3,226,400	$56.67M	7.4%	$16.75	0.0%	COM	56565P103
VOR	VOR BIOPHARMA INC	3,617,354	$47.31M	6.2%	$20.89	-10.8%	COM NEW	929033207
REPL	REPLIMUNE GROUP INC	2,808,368	$27.3M	3.6%	$11.28	-24.7%	COM	76029N106
BCYC	BICYCLE THERAPEUTICS PLC	3,468,430	$24.56M	3.2%	$18.38	—	SPONSORED ADS	088786108
CBIO	CRESCENT BIOPHARMA INC.	1,677,852	$19.9M	2.6%	$12.74	0.0%	COM	G2545C104
ENGNW	ENGENE HOLDINGS INC	2,878,148	$8.519M	1.1%	$0.63	—	W EXP 10/31/2028	29286M113